Five-year survival for distant-stage prostate cancer improved from 2011 to 2016.
Interview study reveals men’s perception and concerns related to their prostate cancer journey.
Incidence of MACE 20.6% within 365 days in patients at increased CV risk.
Researchers examined the efficacy and safety of pegloticase in combination with methotrexate in patients with uncontrolled gout.
New findings could allow clinicians to have more nuanced discussions with patients who have chronic kidney disease regarding the long-term risks associated with alpha blocker use to control blood pressure.
Ertugliflozin is noninferior to placebo for the primary end point of major adverse cardiovascular events.
Simultaneous bilateral laparoscopic nephrectomy can be done at the time of living donor kidney transplant
Gout was not found to be associated with increased risk for cardiovascular complications in patients with peripheral artery disease.
Researchers evaluated the properties and locations of color-coded dual-energy lesions in patients with gout.
Sitagliptin at time of hospitalization linked to reduced mortality, improved clinical outcomes.